Medidata Moves ‘Upstream’ with Fast Track Acquisition


By Deborah Borfitz

March 17, 2008 | Medidata Solutions has acquired Fast Track Systems Inc., developer of the first protocol-authoring tool certified by the Clinical Data Interchange Standards Consortium (CDISC), eCliniqua learned during an exclusive interview with company representatives last week. The move will drive efficiencies across the clinical research process and further solidify Medidata’s position as leader in electronic data capture (EDC) technology, says CEO Tarek Sherif.

Tarek Sherif  
Tarek Sherif  
The acquisition evolved out of a partnership between the companies that started early last year. The two organizations have a lot of “core similarities” in terms of their goals and approaches to improving the conduct of clinical research, says Sherif, including a relentless drive for efficiencies through standardization and innovative technologies. With Fast Track products in its portfolio, Medidata can accomplish that mission more broadly in terms of protocol development and trial planning, contracting, and negotiations.

Fast Track received CDISC certification last year for its first-of-its-kind structured protocol-design tool. Even on a standalone basis, the application – currently in use by several large pharmaceutical companies – “eases the study start-up process,” says Ed Seguine, Medidata’s new general manager of trial planning solutions (previously CEO of Fast Track Systems). The application captures key concepts and the relationships among those concepts – i.e. “the linkage of study objectives to outcomes to specific tasks, variables, and the analyses being performed” – and uses that information to help generate a protocol document.

CDISC certification is important because it allows the outputs to be consumed by other types of information systems, says Seguine. Structured protocol and statistical design information, a key aspect of the FDA’s plans for electronic data submissions, both help clarify the intent of a study and enable better cross-study data comparisons. Developing trial design standards is consequently one of the key goals for CDISC in 2008.

Medidata Designer, as the protocol-authoring tool is now known, standardize the study design process and eliminate errors associated with protocols authored using traditional tools, says Sherif. The next step will be to automatically populate the metadata contained in the protocol into EDC and information systems for interactive voice response and clinical trial management, to streamline and shorten start-up times.

Ed Seguine  
Ed Seguine  
EDC represents a “huge piece” of the workload for conducting clinical studies, but has been missing time- and cost-saving opportunities “upstream…and downstream of that,” says Seguine. In addition to protocol design, Medidata’s newly acquired products focus on other upfront, operational decision-making, such as how to best contract with investigator sites and CROs.

Medidata Designer is “functionally integrated…right out of the gate,” says Sherif. Fast Track’s better-known investigator site contract benchmarking tool (now Medidata Grants Manager) and outsource planning and contracting solution (Medidata CRO Contractor) are already “standard equipment” at many top pharmaceutical companies.

Ultimately, structuring data in the protocol-design phase could lead to simpler studies with fewer procedures. Complex, procedure-heavy studies have recently been demonstrated by the Tufts Center for the Study of Drug Development to negatively impact clinical trial conduct, says Seguine.

“The integration between protocol design, study design, and EDC must become transparent” if EDC is to continue its aggressive rate of adoption, says Chris Connor, senior research analyst, clinical development, at Health Industry Insights. “If not, EDC will simply amplify study design flaws.”

Fast Track is a “pioneer in eClinical CAD [computer-aided design],” adds Connor. “When combined with Medidata Solutions’ ability to construct and execute increasingly complex clinical trials, the sky’s the limit.”   

Medidata will continue to operate Fast Track’s offices in Conshohocken, PA, and Ross, CA, bringing Medidata offices to a total of eight worldwide, says Sherif.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

gq92112

This Bio•IT World Briefing On “Next-Generation Sequencing,”underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new
platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data.  Download now 



sgi_hybrid

SGI's Meeting Today’s Computational Needs for Science

The quest to better understand disease mechanisms and find new treatments is driven by new laboratory technologies and ever-more sophisticated modeling and simulation efforts. As such, life sciences R&D investigations increasingly are relying on more powerful computing resources. The challenge is how to accommodate the broad mix of applications.

Addressing this issue, this paper produced by the Bio-IT World Custom Publishing Group discusses a new SGI Hybrid Computing Environment approach. It optimally uses shared memory systems, multi-processor clusters, and FPGAs to accelerate computational workflows.



sgi_protm

SGI's Supercharging Proteomics Discovery

The deeper study of proteins and their interactions can reveal scientific information once considered nearly untouchable to scientists and researchers. Today, unprecedented advancements in computing power are enabling the creation of mounds of proteomic based data along with the accompanying bottlenecks data can create.

Rather than just “simplify the experiment” to fit the computational resources an alternative is now available with the SGI Proteomics Appliance. This complimentary white paper, produced by the Bio-IT World Custom Publishing Group, looks at ways to use the Proteomic Appliance to handle the most intensive proteomics computing tasks facing science today.



Life Science Webcasts & Podcasts

Waters

Streamlining the Chromatographic Method Validation Process

waters sm podcast button120Waters® Empower™ 2 Method Validation Manager (MVM) is a business-critical, compliant-ready software that reduces time and costs required to perform chromatographic method validation by as much as 80%. Learn in this podcast how MVM streamlines the method validation process and allows the entire process to be efficiently performed within Empower 2, so fewer software applications need be deployed, validated, and maintained. Download Now


More Podcasts

Job Openings

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD 

 Lilly Singapore Center for Drug Discovery (LSCDD) - Senior Software Engineer
Join a strong team of software engineers in our Integrative Computational Sciences (ICS) at LSCDD. Collaborate with, and help develop integrated applications to process and visualize data from cutting-edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. The Software Engineering team provides computational tools and tailored software solutions that enable the global effort of Tailored Therapeutics; ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time'. For additional information, or to apply visit: LSCDD 

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to bio-itworld@theygsgroup.com.